Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,609.78
(
0.13%
)
US TECH 100
29,808.40
(
0.33%
)
Dow Jones
51,307.79
(
0.45%
)
Brent Oil
96.17
(
0.95%
)
Bitcoin
67,009.84
(
0.49%
)
News Focus
News Focus
Post# of 48316
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

hlegweakreturns

Send PM Follow Ignore
Followers 1
Posts 421
Boards Moderated 0
Alias Born 07/31/2013

hlegweakreturns

Re: erostratus post# 7764

Tuesday, 01/14/2014 10:45:20 AM

Tuesday, January 14, 2014 10:45:20 AM

Post# of 48316
Thank you, if 20% success is encouraging to you
Go for it. Yep it was so encouraging they blazed ahead in finishing recruitment. Let's see, when was this written:

"The company disclosed that 25 patients are now enrolled in their melanoma study and will shortly finish enrollment in their 15 patient Merkel Cell Carcinoma (MCC) study study, both of which are Phase II trials."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote